Skip to main content
. Author manuscript; available in PMC: 2007 Jul 11.
Published in final edited form as: Mech Dev. 2007 Feb 6;124(5):377–389. doi: 10.1016/j.mod.2007.01.005

Table 2.

Expression pattern of arg-1 promoter segments in wild-type, hlh-8 (-) and hlh-2 RNAi animals

arg-1 promoter region (bp) genotypes/treatment GFP expression pattern
vm1 a hmc & enteric muscles gonadal sheath cells pm6 & pm7
pZJ02 [−6240 to −1] WT + + +
hlh-8 (-) b
hlh-2 RNAi c −/+d + e + f
pZJ05 [−6240 to −2972] WT + +
hlh-8 (-) + +
hlh-2 RNAi + f +
pZJ04 [−2824 to −1] WT + +
hlh-8 (-)
hlh-2 RNAi −/+ +
pZJ19 [−436 to −1] WT + +
hlh-8 (-)
hlh-2 RNAi −/+ +
a

Abbreviations used: hmc, head mesodermal cell; vm1, type 1 vulval muscles; enteric muscles, left and right intestinal muscles, anal sphincter and anal depressor; pm6 and pm7, pharyngeal muscles 6 and 7; hlh-8 (-), hlh-8 (nr2061).

b

hlh-8 (-) mutation is a predicted null allele (Corsi et al., 2000).

c

L1 larvae were fed bacteria harboring an hlh-2 RNAi vector or an L4440 empty vector (data not shown), and the GFP expression pattern was observed in at least 30 adult worms for each RNAi treatment.

d

Residual GFP expression in the vm1 was observed in < 25% of the hlh-2 RNAi treated animals; in contrast, GFP expression in the vm1 was observed in at least 91% of the animals in RNAi control group (not shown).

e

GFP expression in the hmc and enteric muscles was unaffected possibly because these cells are already formed during embryogenesis prior to the RNAi treatment.

f

The amount of GFP expression in the gonadal sheath cells was essentially unchanged after hlh-2 RNAi treatment compared to the control group. However, the morphology of the cells was abnormal because the hlh-2 RNAi treatment disrupted their development. Sterility and protruding vulva phenotypes were also observed in the hlh-2 RNAi-treated animals.